Beam Therapeutics stock: an 11.3% weekly surge
Beam Therapeutics stock jumps 11.3%, but the Sell signal holds on
Our view last week
After last week's 7.7% bounce, Beam Therapeutics stock is back on the defensive: -2.7% this week, with sellers again dominating volume (54%) and a distribution phase that's getting sharper. The sell signal is now in its fifth week and, even without fresh downside momentum, shows no sign yet of running out of steam. Weekly technical analysis on one of the more volatile healthcare stocks in our universe.
This week's summary
After last week's 2.7% drop, Beam Therapeutics stock sharply reverses course: +11.3% this week, with buyers firmly back in charge, 84% of volume against 16% for sellers, and an 8% bounce off the 20-day moving average. Under the surface, though, money flow has stayed negative for seven weeks and the weekly MACD is still below its signal line for six: the turn isn't confirmed yet. The Sell signal, now in its sixth week, takes the hit.
IQS Phase
51
ordinary
Signal Strength
2
decline fading out
Sizing
MINIMUM
Ranking
#80 / 93
US stocks
Trade P&L %
-8.10%
from signal to date, no stop loss
Rank position
ranks 80th among the 93 sell signals for US stocks in our ranking, with a signal strength of 2 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
BEAM belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content